PDCD1 and neoplasm: Histopathological evaluation through HE staining revealed a notable reduction in the tumor cell density and pathological nuclear division, lighter nuclear staining, and increased necrotic areas following QRHXF and/or anti-PD-1 treatment (Fig. 1F).